Gastrointestinal tract and nutrition in cystic fibrosis: pathophysiology

Dodge, J. A.
January 1986
Journal of the Royal Society of Medicine (Supplement);Jan1986, Vol. 79 Issue 12, p27
Academic Journal
The article discusses the pathological changes found in the gastrointestinal tract of patients with cystic fibrosis (CF). It describes the histological appearances of the small intestine mucosa in CF uncomplicated by other disease, as well as the salivary secretions in patients. It also discusses the deficiency of fat-soluble vitamins in CF.


Related Articles

  • Fat-soluble vitamin deficiency in children and adolescents with cystic fibrosis. Rana, Malay; Wong-See, Denise; Katz, Tamarah; Gaskin, Kevin; Whitehead, Bruce; Jaffe, Adam; Coakley, John; Lochhead, Alistair // Journal of Clinical Pathology;Jul2014, Vol. 67 Issue 7, p605 

    Aims Determine the prevalence of fat-soluble vitamin deficiency in children with cystic fibrosis (CF) aged ⩽18 years in New South Wales (NSW), Australia, from 2007 to 2010. Methods A retrospective analysis of fat-soluble vitamin levels in children aged ⩽18 years who lived in NSW and...

  • The "Brown Bowel Syndrome": A Case Report. Hosler, James P.; Kimmel, Kenneth K.; Moeller, Donald D. // American Journal of Gastroenterology;Nov1982, Vol. 77 Issue 11, p854 

    Brownish discoloration of the muscular layers of the small intestine has been described in association with deficiency of fat soluble vitamin E occurring in various disorders with malabsorption. A patient presenting with diarrhea ultimately found to have "brown bowel syndrome" is reported with...

  • Nutritional care in children with cystic fibrosis: are our patients becoming better? Gaskin, K J // European Journal of Clinical Nutrition;May2013, Vol. 67 Issue 5, p558 

    Over the last 30 years, major advances have occurred in our understanding of the disorder cystic fibrosis (CF) with the discoveries of the underlying chloride transport defect and the 'CF gene', the CF transmembrane conductance regulator gene. Equally important from a clinical and patient...

  • Suplementacion con vitaminas liposolubles en pacientes con fibrosis quistica: ¿es suficiente con Aquadek's®? González Jiménez, David; Bousoño García, Carlos; Díaz Martin, Juan José; Jiménez Treviño, Santiago // Nutricion Hospitalaria;abr2015, Vol. 31 Issue 4, p1625 

    Introduction and objective: Evaluate the safety and efficacy of a novel polyvitaminic (Aquadek's®) in patients with Cystic Fibrosis (CF). Material and Methods: Prospective, longitudinal and non-randomized study. CF patients with pancreatic insufficiency and clinically stable were given...

  • Oral Supplementation with a Special Additive of Retinyl Palmitate and Alpha Tocopherol Reduces Growth Retardation in Young Pancreatic Duct Ligated Pigs Used as a Model for Children Suffering from Exocrine Pancreatic Insufficiency. Mößeler, Anne; Schmicke, Marion; Höltershinken, Martin; Beyerbach, Martin; Kamphues, Josef // International Journal of Molecular Sciences;Oct2016, Vol. 17 Issue 10, p1 

    Pancreatic exocrine insufficiency (PEI) is a disease of diverse aetiology--e.g., majority of patients suffering from cystic fibrosis (CF) show PEI congenitally. Malnutrition and malabsorption of nutrients impair growth and nutritional status. As reduced fat digestion leads to a deficiency of...

  • Role of Vitamin A in T Cell Homing to the Gut. Iwata, Makoto // Current Immunology Reviews;2006, Vol. 2 Issue 4, p345 

    Vitamin A supplementation significantly reduces infant mortality in developing countries, largely by reducing persistent diarrhea that is often aggravated by malnutrition. Vitamin A contributes to maintaining the integrity of mucosal epithelia and enhancing IgA responses in the gut. Recently, we...

  • Bone turnover markers, osteoprotegerin and RANKL cytokines in children with cystic fibrosis. Ambroszkiewicz, J.; Sands, D.; Gajewska, J.; Chelchowska, M.; Laskowska-Klita, T. // Advances in Medical Sciences (De Gruyter Open);2013, Vol. 58 Issue 2, p338 

    Purpose: Some scientific studies show decreased bone mineral density and increased fracture frequency in adult patients with cystic fibrosis (CF). The mechanism for early bone loss in CF patients are multifactorial: chronic pulmonary inflammation, malnutrition, reduced physical activity, delayed...

  • Gastrointestinal Manifestations of Cystic Fibrosis. Wyllie, Robert // Clinical Pediatrics;Dec1999, Vol. 38 Issue 12, p735 

    Editorial. Discusses the gastrointestinal manifestations of cystic fibrosis. Cause of cystic fibrosis; Functions of cystic fibrosis trans-membrane regulator (CFTR); Information on the abnormalities associated with CFTR.

  • Safety and intestinal tolerance of high-dose enteral antioxidants and glutamine peptides after upper gastrointestinal surgery. Schroeder, J.; Alteheld, B.; Stehle, P.; Cayeux, M.-C.; Chioléro, R. L.; Berger, M. M. // European Journal of Clinical Nutrition;Feb2005, Vol. 59 Issue 2, p307 

    OBJECTIVE:: Safety and intestinal tolerance of an early high-dose enteral administration of antioxidative vitamins, trace elements, and glutamine dipeptides. DESIGN:: open intervention trial. SETTING:: Two university teaching hospitals. PATIENTS:: A total of 14 patients requiring jejunal feeding...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics